Case Comprehensive Cancer Center

Neekkan Dey, a postdoc in the Department of Biochemistry, wrote an article accepted for publication in Molecular Cancer Research Journal by American Association for Cancer Research (AACR). Dey works in J. Alan Diehl’s group based at the Case Comprehensive Cancer Center. Dey’s study, titled…

Presentations, collegial debates, networking, and a spirit of collaboration were the themes throughout the evening at the 2024 Cleveland Gastrointestinal (GI) Oncology Consortium Meeting planned jointly by cancer experts from University Hospitals (UH) and Cleveland Clinic (CCF) with support from…

Co-leaders of Case CCC's Cancer Imaging Program, Agata Exner, PhD (PI) and James Basilion, PhD (MPI) received a four-year, $2.4M NIH grant to continue the development, implementation, and clinical translation of the first prostate cancer cell-targeted ultrasound contrast agent. The research team…

Funding supports newly published findings showing some medications trigger ‘cell blasters’ to kill cancer

Nearly 200 people attended Case CCC's Second Annual Microbiome Workshop Feb. 7-8, 2024. The two-day event focused on the latest developments in microbiome cancer research and covered topics such as microbiome and immunity, metabolism and the microbiome, therapeutic implications of microbiome…

Neekkan Dey, a postdoc in J. Alan Diehl's group in the Department of Biochemistry at Case Comprehensive Cancer Center, had work accepted for publication in the Molecular Cancer Research Journal by the American Association of Cancer Research. The study, “miR-217 regulates normal and tumor cell…

Zhenghe John Wang, PhD, Chair of the Genetics and Genome Sciences Department and co-leader of Case CCC's Cancer Genomics and Epigenomics Program, was awarded a grant for $2,012,500 from National Institutes of Health/National Cancer Institute for his research titled Mechanisms of metabolic…

Reshmi Parameswaran, MS, PhD, member of Case CCC's Immune Oncology Program, was awarded a two-year, $200,000 Established Investigator Grant by the National Scleroderma Foundation. The funding supports her research using BAFF CAR-T treatment for systemic sclerosis. Systemic scleroderma (SSc) is a…

This article originally appeared in the fall/winter 2023 edition of Think magazine. This semester, The Daily will share some of the articles from the latest edition of the magazine. View more stories at case.edu/think. Nearly a year ago, on Feb. 3, just before 9 p.m., Ashley McCollum heard a…

Written by leading science researchers, editors, and journalists, reviews in Nature Cancer's 2023 in Review showcase the most exciting discoveries and the biggest challenges of the year. It's not surprising that research conducted in the lab run by Case CCC's Justin Lathia, PhD, Molecular Oncology…